> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# OnCore Biopharma
- URL: https://www.whiteroseintelligence.com/oncore-biopharma/
- Published: 1999-01-02T21:34:00.000Z
- Updated: 2025-01-03T20:47:58.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #organization

**OnCore Biopharma** was an American pharmaceutical company.

## History

In January 2015, [Tekmira Pharmaceuticals](https://www.whiteroseintelligence.com/Tekmira-Pharmaceuticals) announced it would purchase OnCore in order to "focus on developing hepatitis B virus treatment by combining multiple therapeutic methods." OnCore would become a wholly-owned subsidiary, with ownership over Tekmira transferring in significant part to OnCore shareholders.[\[1\]](#fn1) The merger was completed on March 4, 2015, with OnCore chairman [Vivek Ramaswamy](https://www.whiteroseintelligence.com/Vivek-Ramaswamy) becoming chair of the new merged Tekmira.[\[2\]](#fn2)

## Personnel

| Name                                                                     | Position                                                | Notes                                                                                                                                                                                   |
| ------------------------------------------------------------------------ | ------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Patrick Higgins                                                          | Chief Executive Officer, Co-founder[\[3\]](#fn3)        | Pharmasset, SRx Consulting, Coley Pharmaceuticals, Viropharma, Roche, Schering                                                                                                          |
| Michael McElhaugh                                                        | Chief Operating Officer, Co-founder                     | Bristol-Myers Squibb, Pharmasset, Viropharma, [Merck](https://www.whiteroseintelligence.com/Merck), Thomas Jefferson University                                                         |
| Bryce Roberts                                                            | Chief Legal Officer, Head of Administration, Co-founder | Gilead Sciences, Pharmasset                                                                                                                                                             |
| Michael Sofia                                                            | Chief Scientific Officer, Head of R&D, Co-founder       | Gilead Sciences, Pharmasset, Bristol-Myers Squibb, Transcell Technologies, Eli Lilly, [Baruch S. Blumberg Institute](https://www.whiteroseintelligence.com/Baruch-S-Blumberg-Institute) |
| [Vivek Ramaswamy](https://www.whiteroseintelligence.com/Vivek-Ramaswamy) | Chairman[\[1:1\]](#fn1)[\[2:1\]](#fn2)                  | [Roivant Sciences](https://www.whiteroseintelligence.com/Roivant-Sciences)                                                                                                              |

## External links

- [Crunchbase](https://www.crunchbase.com/organization/oncore-biopharma)

---

1. *Canada’s Tekmira to buy US-based OnCore Biopharma, focus on HBV treatment.* (2015, January 12). Reuters. <http://archive.today/2023.06.26-001352/https://www.reuters.com/article/oncore-ma-tekmira-idUSL3N0UR1EZ20150112> [↩︎](#fnref1) [↩︎](#fnref1:1)
2. Rezler, J. P. (2015, March 4). *Tekmira Announces Completion of the Merger With OnCore Creating a Leading Hepatitis B Solutions Company.* Securities and Exchange Commission. <https://web.archive.org/web/20230626001935/https://www.sec.gov/Archives/edgar/data/1447028/000117184315001290/newsrelease.htm> [↩︎](#fnref2) [↩︎](#fnref2:1)
3. *Leadership Team.* OnCore Biopharma. Retrieved September 13, 2014, from <http://archive.today/2014.09.13-010442/http://www.oncorebiopharma.com/leadershipteam> [↩︎](#fnref3)